| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4757049
Max Phase: Preclinical
Molecular Formula: C23H27N5O3S
Molecular Weight: 453.57
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: N#CC1(NC(=O)[C@@H](Cc2ccccc2)CS(=O)(=O)N2CCN(c3ccccn3)CC2)CC1
Standard InChI: InChI=1S/C23H27N5O3S/c24-18-23(9-10-23)26-22(29)20(16-19-6-2-1-3-7-19)17-32(30,31)28-14-12-27(13-15-28)21-8-4-5-11-25-21/h1-8,11,20H,9-10,12-17H2,(H,26,29)/t20-/m0/s1
Standard InChI Key: SBQYSIFCRNPJJQ-FQEVSTJZSA-N
Associated Targets(Human)
Cathepsin S 3285 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 453.57 | Molecular Weight (Monoisotopic): 453.1835 | AlogP: 1.56 | #Rotatable Bonds: 8 |
| Polar Surface Area: 106.40 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.49 | CX Basic pKa: 6.42 | CX LogP: 1.66 | CX LogD: 1.62 |
| Aromatic Rings: 2 | Heavy Atoms: 32 | QED Weighted: 0.65 | Np Likeness Score: -1.58 |
References
| 1. Schade M,Merla B,Lesch B,Wagener M,Timmermanns S,Pletinckx K,Hertrampf T. (2020) Highly Selective Sub-Nanomolar Cathepsin S Inhibitors by Merging Fragment Binders with Nitrile Inhibitors., 63 (20.0): [PMID:32880457] [10.1021/acs.jmedchem.0c00949] |
Source
Source(1):